New York, NY (PRWEB) September 30, 2013
The birth control safety center at DrugRisk.com has added updated information to the site for women who’ve used the contraceptives Yaz or Yasmin. Recent court records show the number of lawsuits alleging Yaz side effects has dropped as the drug maker increases settlements*.
DrugRisk.com was created to improve the safety of patients taking popular prescription drugs by combining the latest research, safety alerts, recalls and litigation news into one place. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.
The resource center has added warnings from health experts such as the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone, like Yaz and Yasmin, can increase the risk of blood clots.
Due to the number of patients who have filed a Yaz lawsuit alleging side effects, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
DrugRisk has added information showing the maker of Yaz and Yasmin, Bayer, has already spent over $1.4 billion to settle approximately 6,760 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)****. This amounts to over $207,000 per case.
Now, the resource center has learned the latest report from the Judicial Panel on Multidistrict Litigation shows the number of pending claims has fallen slightly from 9,868 on August 15th to 9,838 on September 11*.
Anyone who suffered blood clots, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugRisk Center or speak with a lawyer about their legal options.
Due to the specialized nature of federal MDL courts, patients should seek a lawyer with experience in defective drug litigation. DrugRisk only recommends lawyers who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*JPML, 9/11/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-September-11-2013.pdf
**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****Bayer Stockholder’s newsletter Pg. 64, 7/31/13; stockholders-newsletter-q2-2013.bayer.com/en/bayer-stockholders-newsletter-2q-2013.pdfx